What changed in Eli Lilly’s capital spending (capex) recently?
I don’t have any company-specific capex data in the information provided here, so I can’t say whether Eli Lilly’s capital intensity or capital expenditure has gone up or down, or quantify the change.
If you share the period you mean (for example, 2020–2023, or “last quarter vs. prior year”) or paste the figures (capex, depreciation, or total revenue), I can compute capital intensity (capex ÷ revenue), describe the direction of change, and help identify what likely drove it.
How to measure “capital intensity” for Eli Lilly
“Capital intensity” is usually calculated as capex relative to revenue. Common versions:
- Capex-to-revenue: capex ÷ total revenue
- Capex-to-assets: capex ÷ total assets
- Or capex per unit of output, if a company reports that metric (less common for pharma)
To compare trends, you typically want the same definition and same reporting basis across years (standalone vs. consolidated, IFRS vs. US GAAP, etc.).
What typically drives capex changes at a pharma company like Eli Lilly
If your goal is to interpret the capex trend, the biggest recurring drivers tend to be:
- Building or expanding manufacturing capacity for new products and demand growth
- Tech upgrades in biologics/sterile fill-finish and quality systems
- Capacity moves tied to major launches or lifecycle changes
- Large site initiatives (new plants, expansions, or process lines)
- Capitalized R&D for certain qualifying projects (depending on accounting treatment)
If you tell me which timeframe you’re analyzing, I can map these typical drivers to what you might look for in Lilly’s filings.
Where to find the exact capex/capital intensity numbers
The primary sources are:
- Eli Lilly annual reports / Form 10-K (cash flow capex line items and notes)
- Quarterly reports / Form 10-Q (capex and cash flow)
- Investor presentations sometimes discuss manufacturing expansion plans, which often explain capex swings
If you paste the capex and revenue values (or the relevant sections/links), I’ll calculate the capital-intensity change and summarize it clearly.
Quick next step
Reply with either:
1) the years/quarters you mean plus capex and revenue figures, or
2) the document excerpt (or a link) containing Lilly’s capex and revenue,
and I’ll compute how Lilly’s capital intensity/capex changed and what that implies.